Gabelli & Co Investment Advisers’s AbbVie ABBV Stock Holding History

Gabelli & Co Investment Advisers’s Portfolio ABBV Stock Details ABBV Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$340K	Hold	1,350	–	–	0.05%	216
2026 Q1	$294K	Hold	1,350	–	–	0.04%	207
2025 Q4	$308K	Hold	1,350	–	–	0.05%	188
2025 Q3	$313K	Sell	1,350 -150	-10%	-$30.5K	0.05%	182
2025 Q2	$278K	Hold	1,500	–	–	0.04%	190
2025 Q1	$314K	Hold	1,500	–	–	0.05%	162
2024 Q4	$267K	Sell	1,500 -500	-25%	-$91.9K	0.05%	172
2024 Q3	$395K	Hold	2,000	–	–	0.07%	119
2024 Q2	$343K	Hold	2,000	–	–	0.06%	152
2024 Q1	$364K	Hold	2,000	–	–	0.06%	136
2023 Q4	$310K	Hold	2,000	–	–	0.06%	145
2023 Q3	$298K	Hold	2,000	–	–	0.05%	147
2023 Q2	$269K	Hold	2,000	–	–	0.05%	151
2023 Q1	$319K	Hold	2,000	–	–	0.06%	118
2022 Q4	$323K	Sell	2,000 -77	-4%	-$11.8K	0.07%	147
2022 Q3	$279K	Hold	2,077	–	–	0.04%	267
2022 Q2	$318K	Hold	2,077	–	–	0.04%	273
2022 Q1	$337K	Sell	2,077 -1,000	-32%	-$145K	0.04%	276
2021 Q4	$417K	Sell	3,077 -185	-6%	-$21.9K	0.06%	250
2021 Q3	$352K	Buy	3,262 +1,000	+44%	+$114K	0.04%	281
2021 Q2	$255K	Sell	2,262 -500	-18%	-$56.3K	0.03%	294
2021 Q1	$299K	Buy	2,762 +40	+1%	+$4.28K	0.04%	271
2020 Q4	$292K	Buy	2,722 +145	+6%	+$13.9K	0.05%	212
2020 Q3	$226K	Hold	2,577	–	–	0.04%	173
2020 Q2	$253K	Buy	+2,577	New	+$227K	0.06%	133

Other funds holding ABBV

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return

Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return

Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return

Norges Bank Oslo, Norway $1T AUM

Bank of America Charlotte, North Carolina $1.55T AUM 33.47% 1-Year Est. Return

Gabelli & Co Investment Advisers's ABBV Position: Q2 2026 in Review

Gabelli & Co Investment Advisers held its AbbVie (ABBV) position steady in Q2 2026 at 1,350 shares worth $340K. The position accounts for 0.05% of the portfolio, ranked #216.

Gabelli & Co Investment Advisers first reported a position in ABBV in Q2 2020 and has held it in 25 quarters since. The position peaked at $417K in Q4 2021. 4,193 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

Gabelli & Co Investment Advisers held 1,350 shares of AbbVie worth $340K as of Q2 2026.
Gabelli & Co Investment Advisers left its AbbVie share count unchanged in Q2 2026.
AbbVie made up 0.05% of Gabelli & Co Investment Advisers's portfolio in Q2 2026, its #216 holding.
Gabelli & Co Investment Advisers first reported a position in AbbVie in Q2 2020 and has held it in 25 quarters since.
Gabelli & Co Investment Advisers's AbbVie position peaked at $417K in Q4 2021.
4,193 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Gabelli & Co Investment Advisers's 13F filing for Q2 2026, filed 12 Aug 2026.